Krista L. Lanctot
Sunnybrook Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Krista L. Lanctot as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:19 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06014424 · Cannabidiol Medication Intervention TrialSunnybrook Health Sciences Centre · recruiting · Alzheimer Disease · principal investigator
- Ph3NCT04516057 · Nabilone for Agitation Blinded Intervention TrialSunnybrook Health Sciences Centre · recruiting · Alzheimer Disease, Agitation · principal investigator
- N/ANCT02089945 · Pilot Study of Cognitive and Functional Outcomes Following TAVISunnybrook Health Sciences Centre · completed · Aortic Stenosis
- Ph4NCT00254033 · Apathy Associated With Alzheimer's DiseaseSunnybrook Health Sciences Centre · completed · Dementia, Alzheimer Disease
- Ph4NCT00254020 · The Role of Cytokine-Serotonin Interactions in Post-Stroke DepressionSunnybrook Health Sciences Centre · completed · Depression
- Ph4NCT00254007 · Depression and Traumatic Brain InjurySunnybrook Health Sciences Centre · completed · Depression, Traumatic Brain Injury
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:19 UTC. The ranking covers the 200 most relevant of 46 PubMed records, and a shared surname and initials can bring in a namesake. All 46 on PubMed
- Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.CMAJ · 2003264 citationsRCR 7.4
- Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.J Clin Psychiatry · 2013145 citationsRCR 5.7
- Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.Am J Geriatr Psychiatry · 2019127 citationsRCR 6.7
- Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.J Clin Psychopharmacol · 2008109 citationsRCR 3.5
- Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.JAMA Neurol · 202197 citationsRCR 7.5
- Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.Am J Geriatr Psychiatry · 201287 citationsRCR 3.0
- Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.Clin Pharmacol Ther · 199284 citationsRCR 4.1
- A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.Dement Geriatr Cogn Disord · 200771 citationsRCR 1.8
- Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.Arch Neurol · 200767 citationsRCR 1.9
- Fluoxetine attenuates alcohol intake and desire to drink.Int Clin Psychopharmacol · 199464 citationsRCR 2.8